U.S. Clot Management Devices Market Size & Outlook
Related Markets
U.S. clot management devices market highlights
- The U.S. clot management devices market generated a revenue of USD 934.1 million in 2023 and is expected to reach USD 1,286.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
- In terms of segment, percutaneous thrombectomy devices was the largest revenue generating product in 2023.
- Neurovascular Embolectomy Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Clot management devices market data book summary
| Market revenue in 2023 | USD 934.1 million |
| Market revenue in 2030 | USD 1,286.7 million |
| Growth rate | 4.7% (CAGR from 2023 to 2030) |
| Largest segment | Percutaneous thrombectomy devices |
| Fastest growing segment | Neurovascular Embolectomy Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-directed thrombolysis (CDT) devices, Inferior vena cava filters (IVCF) |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Teleflex Inc, Edwards Lifesciences Corp, LeMaitre Vascular Inc, Cook Medical, DePuy Synthes, iVascular, Vascular Solutions |
Other key industry trends
- In terms of revenue, U.S. accounted for 51.9% of the global clot management devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. clot management devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 199.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clot Management Devices Market Scope
Clot Management Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Vascular Solutions | View profile | 501-1000 | Minneapolis, Minnesota, United States, North America | http://www.vascularsolutions.com |
| iVascular | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | http://www.ivascular.global/ |
| LeMaitre Vascular Inc | View profile | 630 | 63 Second Avenue, Burlington, MA, United States, 01803 | https://www.lemaitre.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | http://www.cookmedical.com |
| Edwards Lifesciences Corp | View profile | 19800 | One Edwards Way, Irvine, CA, United States, 92614 | https://www.edwards.com |
| DePuy Synthes | View profile | 5001-10000 | Raynham, Massachusetts, United States, North America | https://depuysynthes.com |
| Teleflex Inc | View profile | 14500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | https://www.teleflex.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
U.S. clot management devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clot management devices market will help companies and investors design strategic landscapes.
Percutaneous thrombectomy devices was the largest segment with a revenue share of 36.16% in 2023. Horizon Databook has segmented the U.S. clot management devices market based on neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (cdt) devices, inferior vena cava filters (ivcf) covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. clot management devices market holds a dominant market share of 87.25% in 2022 owing to factors such as growing healthcare expenditure, product innovation, a favorable medical funding environment, the presence of advanced medical technology, and a growing population susceptible to cardiovascular diseases.
For instance, in February 2022, the Peter G. Peterson Foundation article reported that the U.S. healthcare ecosystem was ranked sixth in the 2021 World Index on Healthcare Innovation. Moreover, in the analysis, the U.S. was ranked 1st in medical scientific advancement.
Several research bodies have highlighted a strong correlation between Coronary Artery Disease (CAD) & increased chances of developing blood clots. Moreover, as per CDC, 1 in 20 people in the U.S. die due to CAD. In addition, as per the National Institutes of Health, an estimated 18.2 million adults in the country have CAD.
Reasons to subscribe to U.S. clot management devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. clot management devices market databook
-
Our clientele includes a mix of clot management devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. clot management devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. clot management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. clot management devices market size, by percutaneous thrombectomy devices, 2018-2030 (US$M)
U.S. Clot Management Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
